Follow

Qlife Holding AB

Nasdaq First North GM Stockholm (Sweden)

Qlife is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker.
Go to market

Sector:
HEALTH CARE
>
Medical Devices
Healthcare
Rights issue
Price
7.00 SEK
Subscription period
03 Oct - 17 Oct 2022
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
QLIFE
SE0013486552
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Qlife Holding AB with ticker QLIFE
Status
Active
Amount of instruments
11 174 438
Currency
SEK
First trading date
02 Mar 2020
Directed issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
QLIFE TO2
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Qlife Holding AB with ticker QLIFE TO2
Status
Inactive
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume-weighted average trading price between May 22, 2023 - June 2, 2023, however, not less than the share’s quota value and not more than SEK 10 per share.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
QLIFE
SE0013486552
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Qlife Holding AB with ticker QLIFE
Status
Active
Amount of instruments
11 174 438
Currency
SEK
First trading date
02 Mar 2020
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
QLIFE TO1
SE0013719333
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Qlife Holding AB with ticker QLIFE TO1
Status
Archived
Amount of instruments
4 472 600
Currency
SEK
Trading period
02 Mar 2020 - 27 May 2021
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share in the Company for SEK 17.50 per share during the subscription period from May 3, 2021 until May 31, 2021.
Update (03.05.2021): Subscription of warrants in Qlife Holding AB series TO 1 commences today, May 3, 2021.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
QLIFE TO2
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Qlife Holding AB with ticker QLIFE TO2
Status
Inactive
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume-weighted average trading price between May 22, 2023 - June 2, 2023, however, not less than the share’s quota value and not more than SEK 10 per share.
Exercise
Sign in to buy
People
Thomas Warthoe
CEO
Mette Gross
Chairman of the board
John Moll
Board member
Ulrik Harrysson
Board member
Mikael Persson
Board member
Mette-marie Harild
Board member
Thomas Warthoe
Board member
Company Details
Sector
HEALTH CARE

Address
Hamntorget 3
Zip code
252 21
City/district
Helsingborg
Country
Sweden (SE)
Registration number
559224-8040
LEI code
Qlife Holding AB
First trade date
02 Mar 2020
Registration date
31 Oct 2019
Short name
QLIFE

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More